PepSeq Provides Massive Platform for Antibody Analyses Posted Monday December 5, 2022 Technology developed at TGen described in new study
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses Posted Tuesday July 5, 2022 Technology developed by TGen researchers could help fine-tune future vaccines
TGen works with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2, the causative agent of COVID-19 in humans Posted Monday May 16, 2022 Program helps ensure animals and the general public are protected from SARS-Cov-2 and serves as a model for monitoring other zoonotic diseases in the future
TGen, ASU, NAU, UArizona and ADHS compile 100,000 sequenced genomes of COVID Posted Tuesday May 3, 2022 Arizona COVID-19 Genomics Union positions state to play a role in CDC’s national pathogen genomics strategy
TGen’s annual economic impact on Arizona exceeds half a billion dollars Posted Tuesday November 30, 2021 Latest economic-impact report shows that TGen returns $132 for every $1 invested by the State of Arizona
TGen case study documents first reported U.S. transmission of COVID from a pet owner to pets Posted Monday November 1, 2021 Using precision genomic sequencing, TGen matched the exact strain of coronavirus shared among a Phoenix-area owner, his cat and his dog
Citizen-scientist study fuels launch of first interactive U.S. county map of ticks carrying diseases Posted Wednesday October 20, 2021 Study finds ticks carrying disease-causing bacteria in 116 U.S. counties where they have not been previously documented by CDC
TGen looks beyond COVID-19 as it advances pathogen sequencing Posted Thursday July 15, 2021 Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold
Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID-19 Posted Wednesday July 14, 2021 Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseases
TGen COVID-19 variant tracking program receives grant from Taiwan Semiconductor Manufacturing Co. Posted Monday June 7, 2021 TSMC support accelerates TGen’s infectious-disease monitoring of COVID-19 and potential future pandemics